Literature DB >> 18656443

The functional importance of the N-terminal region of human prolylcarboxypeptidase.

J Mallela1, R Perkins, J Yang, S Pedigo, J M Rimoldi, Z Shariat-Madar.   

Abstract

The renin-angiotensin-system cascade pathway generates the vasopressor and prothrombotic hormones, angiotensin II (Ang II) and angiotensin III (Ang III) from angiotensinogen. One of the key enzymes for the generation of angiotensin 1-7 (Ang 1-7) and angiotensin 2-7 (Ang 2-7) from Ang II and III, respectively, is prolylcarboxypeptidase (PRCP). To understand the contribution of the N-terminal region to catalysis, an N-terminal truncated form, lacking 179 N-terminal residues of PRCP (rPRCP(40)) was constructed. The circular dichroism (CD) spectrum of rPRCP(40) illustrated that it was structured with significant helical content as indicated by local minima at approximately 220 and 208nm. The main products of Ang III metabolized by rPRCP(40) were Ang 2-7 plus phenylalanine as determined by LC-MS. Angiotensin I (Ang I) blocked the metabolism of Ang III by rPRCP(40). These investigations showed that the C-terminal region of the rPRCP(40) contributes to PRCP's catalytic function, and provided additional experimental evidence for this suggestion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656443      PMCID: PMC2561253          DOI: 10.1016/j.bbrc.2008.07.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Role of the C-terminal tail on the quaternary structure of aldehyde dehydrogenases.

Authors:  J Rodriguez-Zavala; H Weiner
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

2.  Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells.

Authors:  Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

3.  Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.

Authors:  Y Zhao; Q Qiu; F Mahdi; Z Shariat-Madar; R Røjkjaer; A H Schmaier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

Review 4.  The brain renin-angiotensin system: location and physiological roles.

Authors:  M J McKinley; A L Albiston; A M Allen; M L Mathai; C N May; R M McAllen; B J Oldfield; F A O Mendelsohn; S Y Chai
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

5.  Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.

Authors:  C E Odya; D V Marinkovic; K J Hammon; T A Stewart; E G Erdös
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

6.  Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

7.  Recombinant prolylcarboxypeptidase activates plasma prekallikrein.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

Review 8.  The shift in the "paradigm" of the pharmacology of hypertension.

Authors:  Christodoulos S Flordellis; Dimitrios Goumenos; George Kourounis; Sotirios A Tsementzis; Hervé Paris; Jaannis Vlachojiannis
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 9.  Prolylcarboxypeptidase: a cardioprotective enzyme.

Authors:  J Mallela; J Yang; Z Shariat-Madar
Journal:  Int J Biochem Cell Biol       Date:  2008-02-29       Impact factor: 5.085

Review 10.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
View more
  6 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.

Authors:  S M Chajkowski; J Mallela; D E Watson; J Wang; C R McCurdy; J M Rimoldi; Z Shariat-Madar
Journal:  Biochem Biophys Res Commun       Date:  2010-12-16       Impact factor: 3.575

3.  Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).

Authors:  J Wang; A Matafonov; H Madkhali; F Mahdi; D Watson; A H Schmaier; D Gailani; Z Shariat-Madar
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

4.  Prolyl carboxypeptidase and its inhibitors in metabolism.

Authors:  Jin Kwon Jeong; Sabrina Diano
Journal:  Trends Endocrinol Metab       Date:  2012-12-12       Impact factor: 12.015

Review 5.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

6.  Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains.

Authors:  Cristina S Benton; Brooke H Miller; Sean Skwerer; Oscar Suzuki; Laura E Schultz; Michael D Cameron; J S Marron; Mathew T Pletcher; Tim Wiltshire
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.